Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Immune Pharmaceuticals Operating Income 2010-2018 | IMNPQ

Immune Pharmaceuticals operating income from 2010 to 2018. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  
Immune Pharmaceuticals Annual Operating Income
(Millions of US $)
2017 $-12
2016 $-27
2015 $-16
2014 $-16
2013 $-9
2012 $-9
2011 $-14
2010 $-15
2009 $-19
Immune Pharmaceuticals Quarterly Operating Income
(Millions of US $)
2018-09-30 $-4
2018-06-30 $-3
2018-03-31 $-4
2017-12-31 $-4
2017-09-30 $-3
2017-06-30 $-3
2017-03-31 $-3
2016-12-31 $-16
2016-09-30 $-4
2016-06-30 $-3
2016-03-31 $-4
2015-12-31 $-6
2015-09-30 $-3
2015-06-30 $-3
2015-03-31 $-3
2014-12-31 $-4
2014-09-30 $-6
2014-06-30 $-3
2014-03-31 $-3
2013-12-31 $-3
2013-09-30 $-2
2013-06-30 $-2
2013-03-31 $-2
2012-12-31 $-1
2012-09-30 $-3
2012-06-30 $4
2012-03-31 $-2
2011-12-31 $-3
2011-09-30 $-4
2011-06-30 $-4
2011-03-31 $-3
2010-12-31 $-3
2010-09-30 $-4
2010-06-30 $-4
2010-03-31 $-4
2009-12-31 $-4
2009-09-30 $-5
2009-06-30 $-5
2009-03-31 $-4
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.000B $0.000B
Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Immune's lead program, bertilimumab, is a first-in-class, human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. By blocking eotaxin-1, bertilimumab may prevent the migration and activation of eosinophils and other cells, thus blocking an important inflammatory pathway active in a variety of allergic and immune diseases. Bertilimumab has shown promising clinical activity in bullous pemphigoid and has been studied in other conditions including allergic rhinitis and ulcerative colitis, and may have application in other diseases, including atopic dermatitis, asthma, and other diseases. Immune is also developing NanoCyclo, a nano-encapsulated formulation of cyclosporin, which is in late stage preclinical development for atopic dermatitis and psoriasis.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $161.467B 16.16
Vertex Pharmaceuticals (VRTX) United States $114.331B 29.42
Regeneron Pharmaceuticals (REGN) United States $106.870B 26.14
GSK (GSK) United Kingdom $91.229B 10.90
CSL (CSLLY) Australia $89.634B 0.00
Bristol Myers Squibb (BMY) United States $81.591B 38.33
Gilead Sciences (GILD) United States $79.834B 15.90
Moderna (MRNA) United States $58.057B 0.00
Biogen (BIIB) United States $32.042B 14.67
BioNTech SE (BNTX) Germany $23.475B 197.50
Argenex SE (ARGX) Netherlands $21.524B 0.00
Alnylam Pharmaceuticals (ALNY) United States $18.978B 0.00
Genmab (GMAB) Denmark $18.508B 21.70
Illumina (ILMN) United States $16.097B 114.83
BeiGene (BGNE) Cayman Islands $14.760B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.142B 55.17
Incyte (INCY) United States $12.866B 19.90
Bio-Techne Corp (TECH) United States $12.173B 45.98
Sarepta Therapeutics (SRPT) United States $11.763B 1037.08
QIAGEN (QGEN) Netherlands $9.731B 20.79
Insmed (INSM) United States $8.467B 0.00
Roivant Sciences (ROIV) United Kingdom $8.373B 0.00
Exact Sciences (EXAS) United States $8.350B 0.00
Repligen (RGEN) United States $8.280B 108.16
Ascendis Pharma (ASND) Denmark $8.003B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.984B 26.11
Legend Biotech (LEGN) United States $7.898B 0.00
Vaxcyte (PCVX) United States $7.639B 0.00
Intra-Cellular Therapies (ITCI) United States $6.931B 0.00
Viking Therapeutics (VKTX) United States $6.812B 0.00
Blueprint Medicines (BPMC) United States $6.660B 0.00
Exelixis (EXEL) United States $6.301B 32.47
Halozyme Therapeutics (HALO) United States $5.517B 15.32
Cytokinetics (CYTK) United States $5.150B 0.00
Apellis Pharmaceuticals (APLS) United States $4.946B 0.00
Krystal Biotech (KRYS) United States $4.615B 0.00
Zealand Pharma (ZLDPF) Denmark $4.606B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.591B 0.00
ImmunityBio (IBRX) United States $4.571B 0.00
Nuvalent (NUVL) United States $4.292B 0.00
Alkermes (ALKS) Ireland $3.928B 15.37
Immunovant (IMVT) United States $3.857B 0.00
Axsome Therapeutics (AXSM) United States $3.525B 0.00
Merus (MRUS) Netherlands $3.363B 0.00
Guardant Health (GH) United States $3.361B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.285B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.213B 0.00
SpringWorks Therapeutics (SWTX) United States $3.157B 0.00
Biohaven (BHVN) United States $3.111B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.946B 0.00
Amicus Therapeutics (FOLD) United States $2.926B 0.00
Arcellx (ACLX) United States $2.795B 0.00
MorphoSys AG (MOR) Germany $2.765B 0.00
Certara (CERT) United States $2.718B 62.59
Apogee Therapeutics (APGE) United States $2.710B 0.00
IDEAYA Biosciences (IDYA) United States $2.709B 0.00
Denali Therapeutics (DNLI) United States $2.633B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.622B 0.00
Janux Therapeutics (JANX) United States $2.614B 0.00
Avidity Biosciences (RNA) United States $2.588B 0.00
Iovance Biotherapeutics (IOVA) United States $2.519B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.478B 0.00
Twist Bioscience (TWST) United States $2.377B 0.00
Vericel (VCEL) United States $2.342B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.336B 0.00
CG Oncology (CGON) United States $2.285B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.236B 0.00
Celldex Therapeutics (CLDX) United States $2.216B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.208B 0.00
Arvinas (ARVN) United States $2.206B 0.00
ADMA Biologics Inc (ADMA) United States $2.198B 86.18
Fortrea Holdings (FTRE) United States $2.165B 26.61
Novavax (NVAX) United States $2.141B 0.00
Intellia Therapeutics (NTLA) United States $2.132B 0.00
Geron (GERN) United States $2.058B 0.00
Myriad Genetics (MYGN) United States $2.033B 0.00
Vera Therapeutics (VERA) United States $2.021B 0.00
Bavarian Nordic (BVNRY) Denmark $1.999B 8.71
Beam Therapeutics (BEAM) United States $1.983B 0.00
Kymera Therapeutics (KYMR) United States $1.973B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.947B 0.00
Galapagos (GLPG) Belgium $1.810B 0.00
Zai Lab (ZLAB) China $1.805B 0.00
NeoGenomics (NEO) United States $1.788B 0.00
Sana Biotechnology (SANA) United States $1.686B 0.00
Keros Therapeutics (KROS) United States $1.671B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.640B 12.50
Syndax Pharmaceuticals (SNDX) United States $1.639B 0.00
Edgewise Therapeutics (EWTX) United States $1.634B 0.00
Protagonist Therapeutics (PTGX) United States $1.625B 11.36
Kura Oncology (KURA) United States $1.576B 0.00
Structure Therapeutics (GPCR) United States $1.574B 0.00
Dynavax Technologies (DVAX) United States $1.547B 197.00
Neumora Therapeutics (NMRA) United States $1.546B 0.00
Morphic Holding (MORF) United States $1.544B 0.00
Ligand Pharmaceuticals (LGND) United States $1.511B 24.69
Belite Bio (BLTE) United States $1.452B 0.00
Vir Biotechnology (VIR) United States $1.414B 0.00
Spyre Therapeutics (SYRE) United States $1.372B 0.00
Arcus Biosciences (RCUS) United States $1.358B 0.00
ANI Pharmaceuticals (ANIP) United States $1.331B 16.53
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.317B 0.00
Cullinan Therapeutics (CGEM) United States $1.313B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.313B 0.00
Akero Therapeutics (AKRO) United States $1.266B 0.00
Ginkgo Bioworks Holdings (DNA) United States $1.237B 0.00
MannKind (MNKD) United States $1.225B 150.00
Day One Biopharmaceuticals (DAWN) United States $1.189B 0.00
AbCellera Biologics (ABCL) Canada $1.188B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.152B 0.00
Prothena (PRTA) Ireland $1.087B 0.00
Humacyte (HUMA) United States $1.084B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.061B 0.00
MiMedx (MDXG) United States $1.051B 44.50
Arcturus Therapeutics Holdings (ARCT) United States $1.036B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.003B 0.00
Liquidia Technologies (LQDA) United States $0.982B 0.00
Immatics (IMTX) Germany $0.955B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.938B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.928B 0.00
Gyre Therapeutics (GYRE) United States $0.890B 0.00
Immunome (IMNM) United States $0.882B 0.00
Mesoblast (MESO) Australia $0.862B 0.00
Disc Medicine (IRON) United States $0.856B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.850B 0.00
CureVac (CVAC) Germany $0.844B 0.00
Abivax SA (ABVX) France $0.839B 0.00
Tyra Biosciences (TYRA) United States $0.828B 0.00
PureTech Health (PRTC) United States $0.816B 0.00
Prime Medicine (PRME) United States $0.780B 0.00
Praxis Precision Medicines (PRAX) United States $0.778B 0.00
Nurix Therapeutics (NRIX) United States $0.766B 0.00
89BIO (ETNB) United States $0.765B 0.00
Viridian Therapeutics (VRDN) United States $0.762B 0.00
WAVE Life Sciences (WVE) Singapore $0.756B 0.00
Scholar Rock Holding (SRRK) United States $0.749B 0.00
Cytek Biosciences (CTKB) United States $0.746B 0.00
Nuvation Bio (NUVB) United States $0.739B 0.00
CARGO Therapeutics (CRGX) United States $0.735B 0.00
Pliant Therapeutics (PLRX) United States $0.734B 0.00
Stoke Therapeutics (STOK) United States $0.718B 0.00
Tango Therapeutics (TNGX) United States $0.712B 0.00
REGENXBIO (RGNX) United States $0.707B 0.00
GH Research (GHRS) Ireland $0.704B 0.00
Cogent Biosciences (COGT) United States $0.697B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.696B 0.00
Castle Biosciences (CSTL) United States $0.668B 0.00
ArriVent BioPharma (AVBP) United States $0.652B 0.00
AnaptysBio (ANAB) United States $0.646B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Arbutus Biopharma (ABUS) United States $0.627B 0.00
Pharming Group (PHGUF) Netherlands $0.622B 0.00
ITeos Therapeutics (ITOS) United States $0.620B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.619B 0.00
Mineralys Therapeutics (MLYS) United States $0.617B 0.00
Dianthus Therapeutics (DNTH) United States $0.608B 0.00
HilleVax (HLVX) United States $0.603B 0.00
Oric Pharmaceuticals (ORIC) United States $0.602B 0.00
Pharming Group (PHAR) Netherlands $0.601B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.596B 0.00
Zymeworks (ZYME) United States $0.596B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.571B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.560B 0.00
Third Harmonic Bio (THRD) United States $0.559B 0.00
ALX Oncology Holdings (ALXO) United States $0.555B 0.00
Northwest Biotherapeutics (NWBO) United States $0.549B 0.00
Olema Pharmaceuticals (OLMA) United States $0.538B 0.00
Travere Therapeutics (TVTX) United States $0.534B 0.00
Adaptive Biotechnologies (ADPT) United States $0.532B 0.00
Kyverna Therapeutics (KYTX) United States $0.531B 0.00
PepGen (PEPG) United States $0.530B 0.00
Entrada Therapeutics (TRDA) United States $0.528B 24.81
Y-mAbs Therapeutics (YMAB) United States $0.527B 0.00
IGM Biosciences (IGMS) United States $0.514B 0.00
Aerovate Therapeutics (AVTE) United States $0.509B 0.00
Avid Bioservices (CDMO) United States $0.505B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.504B 0.00
Applied Therapeutics (APLT) United States $0.503B 0.00
Astria Therapeutics (ATXS) United States $0.495B 0.00
MaxCyte (MXCT) United States $0.486B 0.00
Absci (ABSI) United States $0.481B 0.00
Cabaletta Bio (CABA) United States $0.479B 0.00
Fulcrum Therapeutics (FULC) United States $0.475B 0.00
Alector (ALEC) United States $0.474B 0.00
Oculis Holding AG (OCS) Switzerland $0.473B 0.00
Celcuity (CELC) United States $0.472B 0.00
EnGene Holdings (ENGN) United States $0.458B 0.00
Terns Pharmaceuticals (TERN) United States $0.454B 0.00
Voyager Therapeutics (VYGR) United States $0.443B 0.00
Neurogene (NGNE) United States $0.442B 0.00
TScan Therapeutics (TCRX) United States $0.438B 0.00
Annexon (ANNX) United States $0.437B 0.00
Erasca (ERAS) United States $0.430B 0.00
Editas Medicine (EDIT) United States $0.425B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.424B 0.00
Allogene Therapeutics (ALLO) United States $0.420B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.419B 0.00
Ocugen (OCGN) United States $0.409B 0.00
FibroBiologics (FBLG) United States $0.403B 0.00
ACELYRIN, INC (SLRN) United States $0.401B 0.00
Fate Therapeutics (FATE) United States $0.393B 0.00
AC Immune (ACIU) Switzerland $0.393B 0.00
Contineum Therapeutics (CTNM) United States $0.386B 0.00
Anika Therapeutics (ANIK) United States $0.381B 321.38
Biomea Fusion (BMEA) United States $0.376B 0.00
Aura Biosciences (AURA) United States $0.364B 0.00
Jasper Therapeutics (JSPR) United States $0.363B 0.00
Sutro Biopharma (STRO) United States $0.354B 0.00
Shattuck Labs (STTK) United States $0.352B 0.00
Anavex Life Sciences (AVXL) United States $0.350B 0.00
Amarin (AMRN) Ireland $0.345B 0.00
C4 Therapeutics (CCCC) United States $0.343B 0.00
Ventyx Biosciences (VTYX) United States $0.339B 0.00
Precigen (PGEN) United States $0.336B 0.00
Nautilus Biotechnology (NAUT) United States $0.331B 0.00
Tenaya Therapeutics (TNYA) United States $0.328B 0.00
Skye Bioscience (SKYE) United States $0.327B 0.00
Q32 Bio (QTTB) United States $0.327B 0.00
Alto Neuroscience (ANRO) United States $0.323B 0.00
Nkarta (NKTX) United States $0.321B 0.00
MeiraGTx Holdings (MGTX) United States $0.321B 0.00
Urogen Pharma (URGN) United States $0.318B 0.00
Agenus (AGEN) United States $0.317B 0.00
Replimune (REPL) United States $0.313B 0.00
Atea Pharmaceuticals (AVIR) United States $0.304B 0.00
Revance Therapeutics (RVNC) United States $0.302B 0.00
Kamada (KMDA) Israel $0.300B 22.70
GENFIT S.A (GNFT) France $0.295B 0.00
XOMA (XOMA) United States $0.294B 0.00
Mersana Therapeutics (MRSN) United States $0.294B 0.00
Solid Biosciences (SLDB) United States $0.293B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.292B 0.00
CorMedix Inc (CRMD) United States $0.290B 0.00
Inozyme Pharma (INZY) United States $0.290B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.285B 0.00
Adlai Nortye (ANL) Cayman Islands $0.284B 0.00
Poseida Therapeutics (PSTX) United States $0.281B 0.00
23andMe Holding (ME) United States $0.270B 0.00
Emergent Biosolutions (EBS) United States $0.267B 0.00
Rani Therapeutics Holdings (RANI) United States $0.258B 0.00
Caribou Biosciences (CRBU) United States $0.257B 0.00
Candel Therapeutics (CADL) United States $0.256B 0.00
Inovio Pharmaceuticals (INO) United States $0.253B 0.00
Prima BioMed (IMMP) Australia $0.252B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.249B 0.00
Codexis (CDXS) United States $0.240B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.239B 0.00
Zura Bio (ZURA) United States $0.234B 0.00
Werewolf Therapeutics (HOWL) United States $0.233B 0.00
XBiotech (XBIT) United States $0.228B 0.00
UniQure (QURE) Netherlands $0.227B 0.00
2seventy Bio (TSVT) United States $0.224B 0.00
Design Therapeutics (DSGN) United States $0.223B 0.00
Elevation Oncology (ELEV) United States $0.222B 0.00
Innate Pharma S.A (IPHA) France $0.222B 0.00
Ovid Therapeutics (OVID) United States $0.217B 0.00
Renovaro (RENB) United States $0.217B 0.00
Invivyd (IVVD) United States $0.216B 0.00
Coherus BioSciences (CHRS) United States $0.216B 0.00
ChromaDex (CDXC) United States $0.214B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.208B 0.00
Scilex Holding (SCLX) United States $0.201B 0.00
Boundless Bio (BOLD) United States $0.190B 0.00
Compugen (CGEN) Israel $0.190B 0.00
INmune Bio (INMB) United States $0.189B 0.00
Compass Therapeutics (CMPX) United States $0.187B 0.00
Inventiva S.A (IVA) France $0.187B 0.00
Puma Biotechnology (PBYI) United States $0.184B 11.55
Trevi Therapeutics (TRVI) United States $0.182B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.179B 0.00
Lifecore Biomedical (LFCR) United States $0.175B 0.00
Abeona Therapeutics (ABEO) United States $0.173B 0.00
G1 Therapeutics (GTHX) United States $0.173B 0.00
Greenwich LifeSciences (GLSI) United States $0.173B 0.00
Adocia (ADOCY) France $0.170B 0.00
Oncobiologics (OTLK) United States $0.169B 0.00
Cartesian Therapeutics (RNAC) United States $0.168B 0.00
Rezolute (RZLT) United States $0.167B 0.00
Opthea (OPT) Australia $0.165B 0.00
Alimera Sciences (ALIM) United States $0.165B 0.00
Sagimet Biosciences (SGMT) United States $0.164B 0.00
X4 Pharmaceuticals (XFOR) United States $0.164B 0.00
Adverum Biotechnologies (ADVM) United States $0.162B 0.00
Kodiak Sciences (KOD) United States $0.159B 0.00
Cellectis S.A (CLLS) France $0.151B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.149B 0.00
Molecular Partners AG (MOLN) Switzerland $0.148B 0.00
Seres Therapeutics (MCRB) United States $0.148B 0.00
ScPharmaceuticals (SCPH) United States $0.145B 0.00
Cardiff Oncology (CRDF) United States $0.142B 0.00
Repare Therapeutics (RPTX) Canada $0.142B 0.00
Rapt Therapeutics (RAPT) United States $0.141B 0.00
I-Mab (IMAB) China $0.141B 0.00
TELA Bio (TELA) United States $0.139B 0.00
CytomX Therapeutics (CTMX) United States $0.136B 8.75
Syros Pharmaceuticals (SYRS) United States $0.134B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.132B 0.00
Gossamer Bio (GOSS) United States $0.131B 0.00
BioStem Technologies (BSEM) $0.129B 0.00
Adicet Bio (ACET) United States $0.122B 0.00
CervoMed (CRVO) United States $0.122B 0.00
ATyr Pharma (LIFE) United States $0.121B 0.00
Vigil Neuroscience (VIGL) United States $0.120B 0.00
Nuvectis Pharma (NVCT) United States $0.117B 0.00
Seer (SEER) United States $0.115B 0.00
Adagene (ADAG) China $0.115B 0.00
Sangamo Therapeutics (SGMO) United States $0.113B 0.00
DBV Technologies S.A (DBVT) France $0.111B 0.00
Coya Therapeutics (COYA) United States $0.110B 0.00
Immunic (IMUX) United States $0.110B 0.00
PDS Biotechnology (PDSB) United States $0.108B 0.00
Omega Therapeutics (OMGA) United States $0.108B 0.00
Allakos (ALLK) United States $0.107B 0.00
BeyondSpring (BYSI) United States $0.106B 0.00
DiaMedica Therapeutics (DMAC) United States $0.105B 0.00
VistaGen Therapeutics (VTGN) United States $0.105B 0.00
Akoya Biosciences (AKYA) United States $0.104B 0.00
Clearside Biomedical (CLSD) United States $0.104B 0.00
BioHarvest Sciences (CNVCF) Canada $0.103B 0.00
Verastem (VSTM) United States $0.101B 0.00
Bluebird Bio (BLUE) United States $0.098B 0.00
Athira Pharma (ATHA) United States $0.097B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.097B 0.00
Eton Pharmaceuticals (ETON) United States $0.093B 90.50
Vor Biopharma (VOR) $0.091B 0.00
Precision BioSciences (DTIL) United States $0.089B 0.00
Ikena Oncology (IKNA) United States $0.086B 0.00
Connect Biopharma Holdings (CNTB) United States $0.086B 0.00
InflaRx (IFRX) Germany $0.084B 0.00
Oncolytics Biotech (ONCY) Canada $0.082B 0.00
IO Biotech (IOBT) Denmark $0.082B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.081B 0.00
Gritstone Bio (GRTS) United States $0.081B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.081B 0.00
Galena Biopharma (SLS) United States $0.081B 0.00
Cognition Therapeutics (CGTX) United States $0.079B 0.00
Elutia (ELUT) United States $0.078B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.078B 0.00
Cue Biopharma (CUE) United States $0.077B 0.00
Elicio Therapeutics (ELTX) United States $0.077B 0.00
Spero Therapeutics (SPRO) United States $0.077B 2.78
Eupraxia Pharmaceuticals (EPRX) Canada $0.075B 0.00
Alpha Teknova (TKNO) United States $0.075B 0.00
HOOKIPA Pharma (HOOK) United States $0.074B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.074B 0.00
BioAtla (BCAB) United States $0.073B 0.00
Instil Bio (TIL) United States $0.072B 0.00
VTv Therapeutics (VTVT) United States $0.072B 0.00
Genelux (GNLX) United States $0.072B 0.00
Passage Bio (PASG) United States $0.071B 0.00
Benitec Biopharma (BNTC) United States $0.071B 0.00
Earth Science Tech (ETST) United States $0.070B 0.00
Aileron Therapeutics (ALRN) United States $0.069B 0.00
Atara Biotherapeutics (ATRA) United States $0.068B 0.00
Lantern Pharma (LTRN) United States $0.068B 0.00
Intensity Therapeutics (INTS) United States $0.068B 0.00
Checkpoint Therapeutics (CKPT) United States $0.067B 0.00
Annovis Bio (ANVS) United States $0.067B 0.00
BioXcel Therapeutics (BTAI) United States $0.067B 0.00
Entera Bio (ENTX) Israel $0.067B 0.00
Dyadic (DYAI) United States $0.066B 0.00
Rallybio (RLYB) United States $0.066B 0.00
MediciNova (MNOV) United States $0.065B 0.00
Bionano Genomics (BNGO) United States $0.065B 0.00
China Health Industries Holdings (CHHE) China $0.065B 0.00
AVROBIO (AVRO) United States $0.065B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.064B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.063B 0.00
Curis (CRIS) United States $0.063B 0.00
Affimed (AFMD) Germany $0.062B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.061B 0.00
CalciMedica (CALC) United States $0.061B 0.00
AN2 Therapeutics (ANTX) United States $0.061B 0.00
Turnstone Biologics (TSBX) United States $0.061B 0.00
Genenta Science S.p.A (GNTA) Italy $0.060B 0.00
Leap Therapeutics (LPTX) United States $0.060B 0.00
Enzo Biochem (ENZ) United States $0.059B 0.00
Celularity (CELU) United States $0.058B 0.00
Theratechnologies (THTX) Canada $0.057B 0.00
Cidara Therapeutics (CDTX) United States $0.057B 0.00
LENZ Therapeutics (LENZ) United States $0.057B 0.00
Immix Biopharma (IMMX) United States $0.055B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.054B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.054B 0.00
Equillium (EQ) United States $0.052B 0.00
Lexaria Bioscience (LEXX) Canada $0.051B 0.00
Carmell (CTCX) United States $0.051B 0.00
ARCA Biopharma (ABIO) United States $0.050B 0.00
Kezar Life Sciences (KZR) United States $0.050B 0.00
Ocean Biomedical (OCEA) United States $0.050B 0.00
Kronos Bio (KRON) United States $0.047B 0.00
Aligos Therapeutics (ALGS) United States $0.047B 0.00
IN8bio (INAB) United States $0.045B 0.00
Beyond Air (XAIR) United States $0.044B 0.00
NextCure (NXTC) United States $0.044B 0.00
Clene (CLNN) United States $0.044B 0.00
Ocuphire Pharma (OCUP) United States $0.044B 0.00
Dare Bioscience (DARE) United States $0.044B 0.00
Aadi Bioscience (AADI) United States $0.043B 0.00
HCW Biologics (HCWB) United States $0.041B 0.00
Immuneering (IMRX) United States $0.041B 0.00
OKYO Pharma (OKYO) $0.040B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.040B 0.00
NKGen Biotech (NKGN) United States $0.039B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.039B 0.00
Eyenovia (EYEN) United States $0.038B 0.00
Cyclo Therapeutics (CYTH) United States $0.037B 0.00
Fortress Biotech (FBIO) United States $0.036B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.036B 0.00
Quince Therapeutics (QNCX) United States $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.034B 0.00
MiNK Therapeutics (INKT) United States $0.033B 0.00
Cara Therapeutics (CARA) United States $0.033B 0.00
Promis Neurosciences (PMN) Canada $0.032B 0.00
Estrella Immunopharma (ESLA) United States $0.032B 0.00
Evogene (EVGN) Israel $0.032B 0.00
Pluri (PLUR) Israel $0.031B 0.00
Spruce Biosciences (SPRB) United States $0.030B 0.00
Bolt Biotherapeutics (BOLT) United States $0.029B 0.00
BioAffinity Technologies (BIAF) United States $0.028B 0.00
RenovoRx (RNXT) United States $0.028B 0.00
Apollomics (APLM) United States $0.027B 0.00
Femasys (FEMY) United States $0.026B 0.00
UNITY Biotechnology (UBX) United States $0.026B 0.00
Lisata Therapeutics (LSTA) United States $0.026B 0.00
BRIACELL THERAP (BCTX) Canada $0.025B 0.00
Aprea Therapeutics (APRE) United States $0.025B 0.00
SAB Biotherapeutics (SABS) United States $0.024B 0.00
Cocrystal Pharma (COCP) United States $0.024B 0.00
Forte Biosciences (FBRX) United States $0.023B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.022B 0.00
Biora Therapeutics (BIOR) United States $0.022B 0.00
Purple Biotech (PPBT) Israel $0.022B 0.00
Vincerx Pharma (VINC) United States $0.020B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.020B 0.00
Evaxion Biotech (EVAX) Denmark $0.019B 0.00
Sensei Biotherapeutics (SNSE) United States $0.019B 0.00
Aptose Biosciences (APTO) Canada $0.019B 0.00
Lumos Pharma (LUMO) United States $0.019B 0.00
Synlogic (SYBX) United States $0.018B 0.00
KALA BIO (KALA) United States $0.018B 0.00
Kintara Therapeutics (KTRA) United States $0.018B 0.00
Aytu BioPharma (AYTU) United States $0.017B 0.00
VBI Vaccines (VBIV) United States $0.017B 0.00
Talis Biomedical (TLIS) United States $0.017B 0.00
Orgenesis (ORGS) United States $0.017B 0.00
Galecto (GLTO) Denmark $0.017B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.016B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.015B 0.00
Senti Biosciences (SNTI) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Imunon (IMNN) United States $0.014B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.014B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.013B 0.00
Galera Therapeutics (GRTX) United States $0.013B 0.00
Elevai Labs (ELAB) United States $0.012B 0.00
Semper Paratus Acquisition (TVGN) United States $0.012B 0.00
AEterna Zentaris (AEZS) Canada $0.012B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.012B 0.00
Chemomab Therapeutics (CMMB) Israel $0.012B 0.00
Moleculin Biotech (MBRX) United States $0.011B 0.00
Monopar Therapeutics (MNPR) United States $0.011B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.010B 0.00
Eterna Therapeutics (ERNA) United States $0.010B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
NuCana (NCNA) United Kingdom $0.010B 0.00
BioCardia (BCDA) United States $0.009B 0.00
ABVC BioPharma (ABVC) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Biorestorative Therapies (BRTX) United States $0.008B 0.00
Vaccinex (VCNX) United States $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
Trevena (TRVN) United States $0.007B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Longeveron (LGVN) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
Entero Therapeutics (ENTO) United States $0.007B 0.00
Psyence Biomedical (PBM) United States $0.006B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
Atrinsic (PTIX) United States $0.006B 0.00
Telesis Bio (TBIO) United States $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Kineta (KA) United States $0.006B 0.00
Enveric Biosciences (ENVB) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
ThermoGenesis Holdings (THMO) United States $0.004B 0.00
Cingulate (CING) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
NexImmune (NEXI) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
Novogen (KZIA) Australia $0.004B 0.00
Alzamend Neuro (ALZN) United States $0.004B 0.00
Virios Therapeutics (VIRI) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.003B 0.00
TRACON Pharmaceuticals (TCON) United States $0.003B 0.36
Exicure (XCUR) United States $0.003B 0.17
Aptevo Therapeutics (APVO) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Mustang Bio (MBIO) United States $0.003B 0.00
Seelos Therapeutics (SEEL) United States $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.003B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Allarity Therapeutics (ALLR) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Sunshine Biopharma (SBFM) United States $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00